Additionally, STAT3 is involved in neuroendocrine differentiation, promoting resistance to androgen deprivation therapy and taxane-containing chemotherapy, displaying a more aggressive and lethal PCa phenotype [34]. This evidence concerns the gene STAT3 and posterior cortical atrophy.